Pharmafile Logo
Pharmafocus logo
Advanced Search

eular 2016

Showing 3 posts of 3 posts found.

lab

GSK, Janssen RA treatment meets co-primary endpoints in Phase III trial

June 9, 2016
Research and Development GSK, Janssen, eular 2016, rheumatoid arthritis, sirukumab

GSK (LSE: GSK) and Janssen, a division of Johnson and Johnson, have announced data from a pivotal Phase III study …

News
samsung

New data on biosimilars of the big three anti-TNF drugs presented at EULAR 2016

June 8, 2016
Research and Development, Sales and Marketing Benepali, Biogen, Enbrel, Flixabi, Humira, Remicade, Samsung Bioepis, biosimilars, eular 2016, sb5

Samsung Bioepis has presented data at EULAR 2016 on three biosimilars of the highly selling anti-TNF drugs Remicade (infliximab), Enbrel …

News
novartis_side_building

Novartis to compare Cosentyx with Humira in new clinical trials

June 8, 2016
Research and Development Cosentyx, Humira, Novartis, comparison, eular 2016

Novartis has announced that it plans to directly compare Cosentyx (secukinumab) versus Humira (adalimumab) in patients with ankylosing spondylitis and …

News
The Gateway to Local Adoption Series

Latest content

CeramTec expands German production capacity for orthopaedic ceramics

October 2, 2026

Migraine annual economic and quality-of-life burden in UK

October 1, 2026

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026

Phoenix Labs acquires Kent Pharma

September 29, 2026

Astoriom acquires Sampled’s UK stability storage operations

September 28, 2026